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Abstract
Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease associated with
autoantibodies against the hemidesmosomal proteins BP180 and BP230. In the IgG passive
transfer model of BP, blister formation is triggered by anti-BP180 IgG and depends on
complement activation, mast cell degranulation, and neutrophil recruitment. Mice lacking
neutrophil elastase (NE) do not develop experimental BP. Here, we demonstrated that NE
degrades recombinant mouse BP180 within the immunodominant extracellular domain at amino
acid positions 506 and 561, generating peptide p561 and peptide p506. Peptide p561 is
chemotactic for neutrophils both in vitro and in vivo. Local injection of NE into B6 mice recruits
neutrophils to the skin, and neutrophil infiltration is completely blocked by co-injection with the
NE inhibitor α1-proteinase inhibitor. More importantly, NE directly cleaves BP180 in mouse and
human skin, as well as the native human BP180 trimer molecule. These results demonstrate that (i)
NE directly damages the extracellular matrix and (ii) NE degradation of mouse BP180 generates
neutrophil chemotactic peptides that amplify disease severity at the early stage of the disease.
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1. Introduction
Bullous pemphigoid (BP)1 is an autoimmune skin blistering disease that primarily afflicts
the elderly (Lever, 1953). BP is characterized by the development of tense, fluid-filled
blisters on the body, separation of the epidermis from the dermis, an intense inflammatory
infiltrate, and the destruction of components of the hemidesmosome and extracellular matrix
(Jordon et al., 1967; Stanley, 1999). Patients exhibit circulating and tissue-bound
autoantibodies directed against the hemidesmosomal antigens BP230 and BP180 (Stanley,
1999; Stanley et al., 1981). BP180, also known as BPAG2 or type XVII collagen, is the
primary target of the pathogenic autoantibodies in BP patients (Bedane et al., 1997; Diaz et
al., 1990; Giudice et al., 1992; Giudice et al., 1993; Hopkinson et al., 1992; Labib et al.,
1986; Mutasim et al., 1985; Nishizawa et al., 1993). A type II transmembrane glycoprotein
that exists as a homo-trimer in the skin (Hirako et al., 1996; Van den Bergh et al., 2006),
BP180's amino-terminal portion localizes to the hemidesmosomal plaque and the carboxyl-
terminal region extends into the extracellular region of the basement membrane zone (BMZ)
(Giudice et al., 1992; Hopkinson et al., 1992; Ishiko et al., 1993). The extracellular portion
of BP180 consists of 15 collagen domains interrupted by 16 non-collagen (NC) sequences
(Giudice et al., 1992). The membrane-proximal non-collagen linker domain (termed
NC16A) harbors multiple epitopes recognized by BP autoantibodies (Giudice et al., 1993;
Zillikens et al., 1997). The human BP180 shares high overall homology with the murine
BP180 (mBP180); but mBP180 contains 13 collagen domains and 14 non-collagen domains
(Li et al., 1993). Moreover, the NC16A domain is very poorly conserved in the murine
protein (termed NC14A), resulting in a lack of immune-reactivity across these two species
(Liu et al., 1993).
We have previously described a mouse model of BP in which disease is induced by the
passive transfer of antibodies directed against mouse BP180 (Liu et al., 1993). Neonatal
BALB/c mice injected with these antibodies develop a blistering skin disease that exhibits
the key immunopathologic features of BP. Using this animal model, we have shown that the
antibody-induced lesion formation is dependent on complement activation, mast cell
degranulation, and neutrophil infiltration of the upper dermis (Chen et al., 2001; Liu et al.,
1995; Liu et al., 1997).
Upon activation, infiltrating neutrophils secrete proteolytic enzymes known to degrade the
extracellular matrix, including neutrophil elastase (NE), matrix metallopeptidase-9
(MMP-9), cathepsin G, and collagenase (Janoff, 1985; Senior and Campbell, 1983; Weiss,
1989). These proteinases, along with others such as plasmin and plasminogen activators,
have been detected in BP blister fluid and within lesional/perilesional skin sites on BP
patients (Gissler et al., 1992; Grando et al., 1989a; Grando et al., 1989b; Kramer and
Reinartz, 1993; Oikarinen et al., 1983; Stahle-Backdahl et al., 1994; Welgus et al., 1986). In
experimental BP, both NE and MMP-9 are required for blister formation (Liu et al., 2000a;
Liu et al., 1998). MMP-9 is the upstream actor that proteolytically inactivates the
physiological inhibitor of NE (α1-proteinase inhibitor), while NE directly cleaves
extracellular matrix proteins, including BP180, resulting in DEJ separation (Liu et al.,
2000a; Liu et al., 2000b). These data indicate that NE contributes to the pathogenesis of
experimental BP by directly damaging cell-matrix adhesion molecules, which ultimately
leads to the detachment of the basal keratinocytes from the basement membrane. However,
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mice lacking NE are unable to sustain recruitment of neutrophils to the skin, suggesting that
NE may also contribute to disease progression through its role in recruitment of neutrophils
to lesional skin (Liu et al., 2000b). In this study, we investigate the ability of NE to degrade
BP180 and examine the functions of the degradation products in vitro and in vivo.
2. Results
2.1. NE degrades recombinant murine BP180 antigen in vitro
To demonstrate that NE directly degrades the BP180 antigen, we performed in vitro
degradation assays by incubating purified NE with a purified recombinant protein
(mBP180ABC) containing NC14A and part of the C13 domain as a substrate (Figure 1). NE
cleaved mBP180ABC into 3 distinct fragments, with molecular weights of 15, 12, and 8 kD
as determined by SDS-PAGE separation followed by Coomassie blue staining (Figure 1A,
Lanes 2–6). No degradation products were observed in the reaction lacking NE (Figure 1A,
Lane 7), or in the sample containing NE at time 0 (Figure 1A, Lane 1). The digestion
mixtures were also further characterized by immunoblot analysis using an anti-mBP180
antiserum. The anti-mBP180ABC antibodies detected the three bands identified by
Coomassie blue staining (Figure 1B, lanes 2–6), and the 12 kD fragment is the predominant
band detected after two hours of digestion (Figure 1B, Lane 4). Thus, each of the digestion
products contained one or more epitopes recognized by the anti-BP180 antiserum. The time
course study also revealed a sequential cleavage of the antigen: the 15 kD and 12 kD
fragments appear before the 8 kD fragment. Using mass spectrometry, we identified the
location of three NE cleavage sites at amino acid position 506, 561, and 592, respectively in
mBP180ABC (Figure 1C). Cleavage at these three locations produces three peptides, p506,
p561, and p592.
Having demonstrated that purified NE degrades mBP180ABC, we next investigated the
degradative capability of NE released from neutrophils. Purified neutrophils from WT (NE
+/+) and NE-deficient (NE−/−) mice were degranulated with PMA, and the supernatants
were collected and assayed for their ability to degrade mBP180ABC. Digestion with
supernatant from NE+/+ neutrophils yielded two fragments, corresponding with the 15 and
12 kD fragments generated by digestion with purified NE (Figure 2, Lanes 2 and 3). A very
faint 8 kD band was also seen in the NE+/+ supernatant digestion when sample was over-
loaded (data not shown). Digestion of mBP180ABC by NE+/+ neutrophil supernatant was
completely blocked by addition of the NE inhibitor α1-PI to the reaction mixture (Figure 2,
Lane 4), indicating that NE is the proteinase present in the supernatant that is critical for
digestion of the BP180 antigen. Supernatant from the NE−/− neutrophils did not digest
mBP180ABC (Figure 2, Lane 5), further confirming that NE is the major enzyme that is
responsible for BP180 degradation.
2.2. Neutrophil elastase-cleaved mBP180 fragments are chemotactic for neutrophils
We previously showed that mice lacking NE are unable to sustain recruitment of neutrophils
to the skin (Liu et al., 2000b). These data indicate that NE may be involved in neutrophil
infiltration into lesional skin in experimental BP. We hypothesized that NE digestion of
extracellular matrix components generates chemotactic peptides that recruit inflammatory
cells to the skin. To investigate this proposed mechanism of NE-mediated neutrophil
recruitment, we first tested the three peptides identified in Section 2.1 for neutrophil
chemotactic activity using a modified Boyden chamber. Peptides p506 and p592 did not
exhibit chemotactic activity above the activity observed in the PBS control (Figure 3A, bars
1, 3–5, 9–11). However, peptide 561 demonstrated strong chemotactic activity at
concentrations ranging from 10−5 M to 10−7 M (Figure 3A, bars 6–8).
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We next investigated the chemotactic activity of the three peptides in vivo. Neonatal
C57BL/6J mice were injected intradermally with PBS, p506, p561, p592, or IL-8, a
neutrophil chemoattractant, and neutrophil infiltration was quantified by measuring
myeloperoxidase activity (MPO) in the skin. Neutrophil recruitment to the skin in the mice
injected with p506 or p592 was equivalent to PBS-injected mice (Figure 3B, bars 1, 3–4, 7–
8). In contrast, mice injected with p561 exhibited a significant increase in the level of
neutrophil infiltration to the skin, although not as high a level as the mice injected with IL-8
(Figure 3B, bars 2, 5–6). Taken together, peptide p561 generated by NE degradation of
BP180 acts as a neutrophil chemoattractant both in vitro and in vivo.
2.3. Local injection of NE induces neutrophil infiltration
If NE directly damages the extracellular matrix and generates a chemotactic factor that
recruits neutrophils to the skin, then directly injecting NE into neonatal mice should be
sufficient to trigger BP180 degradation and neutrophil infiltration, even in the absence of
pathogenic anti-BP180 antibodies and the other inflammatory cells and cytokines known to
contribute to the pathogenesis of BP. To test this hypothesis, we injected neonatal B6 mice
intradermally with NE and quantified neutrophil infiltration to the skin. As expected, NE
injection significantly increased the number of neutrophils present in the skin as evidenced
by routine histology examination (Figure 4A, left panel) and by enzymatic activity assay of
the neutrophil marker MPO (Figure 4B). Prolonged NE incubation led to histological
separation of epidermis from the underlying dermis (Figure 4A, middle panel). The
neutrophil recruitment and dermalepidermal separation observed with NE injection is
completely blocked by co-injection with α1-PI (Figure 4A, right panel). These results
suggest that NE cleaves BP180 and degradation of BP180 results in neutrophil infiltration.
To determine the ability of NE to directly degrade BP180 in mouse skin, we incubated
epidermis from neonatal mice with NE at 37°C. After 30 minutes of incubation, the full
length 180 kDa protein was converted into a lower molecular weight band (Figure 4C, lane
3). Epidermis incubated at 37°C for 30 minutes without NE did not exhibit detectable
degradation (Figure 4C, lane 2). In addition, α1-PI co-incubation completely abolished
BP180 cleavage by NE (Figure 4C, lane 4), further confirming the specificity of NE for
BP180 degradation.
2.4. Neutrophil elastase cleaves the native human BP180 molecule
BP180 exists as a trimer in the skin. To determine whether NE degrades the native human
BP180 trimer molecule, we first detected BP180 degradation in the human skin epidermis
incubated with NE by immunoblotting. Similar to the mouse epidermal BP180 degradation
(Figure 4C), the full-length human BP180 in the skin was cleaved into a lower molecular
weight band when incubated with NE (Figure 5A, lane 2). To directly show that NE
degrades human BP180 trimer, protein extracts of the cultured human primary keratinocytes
were incubated with NE at 37°C for 30 min, separated by SDS-PAGE gel under native or
denaturing/reducing conditions, and then probed by anti-NC16A antibody. As expected,
human BP180 trimer and monomer bands were seen under the native and reducing/
denaturing conditions, respectively (Figure 5B, top panel, lanes 1,2). In the presence of NE,
a trimer band with lower molecular weight and cleaved monomer bands were identified
under the native and reducing/denaturing conditions, respectively (Figure 5B, top panel,
lanes 3,4). Small BP180 fragments were also recovered by running samples in 18%
SDS=PAGE gel (Figure 5B. bottom panel, lane 2). These results demonstrate that NE is
capable of degrading native BP180 trimer.
Lin et al. Page 4














Accumulation of neutrophils in the skin is required for blister formation in experimental BP
(Liu et al., 1995; Liu et al., 1998). While the degranulation of mast cells releases
chemoattractants that initially recruit neutrophils to the skin, a secondary amplification
phase of neutrophil accumulation occurs that is not mediated by mast cells. In this study, we
provide evidence that NE, an enzyme secreted by the initial wave of activated neutrophils,
cleaves mBP180 within the immunodominant domain NC14A and generates a 12 kD
digestion product that is chemotactic for neutrophils. This 12 kD fragment, referred to as
p561, is chemotactic for neutrophils both in vitro and in vivo. We also found that local
injection of NE causes dermal-epidermal separation and neutrophil infiltration to the skin in
mice. Importantly, NE also cleaves the human native BP180 trimer molecule. Taken
together, we conclude that NE digests BP180 into a chemoattractant fragment that recruits
neutrophils to the skin in mice. This second wave of neutrophil recruitment amplifies the
inflammatory and proteolytic environment required for the extensive extracellular matrix
disruption that occurs prior to dermal-epidermal separation and blister formation in
experimental BP.
BP180 is not the only basement membrane protein that generates chemotactic fragments
following proteolytic cleavage. Fragments derived from a number of collagens, elastins, and
laminins are also reported to attract inflammatory cells, such as neutrophils, monocytes, and
macrophages (Adair-Kirk and Senior, 2008; Clark et al., 1988; Houghton et al., 2006;
Hunninghake et al., 1981; Senior et al., 1980; Weathington et al., 2006). Laminin-332
digestion with NE produces fragments chemotactic for neutrophils, as are fragments
generated by laminin-111 digestion with NE or cathspesin G (Gresham et al., 1996; Mydel
et al., 2008). In chronic obstructive pulmonary disease, elastin degradation by MMP-12
generates chemotactic fragments that recruit monocytes to the alveolar airspace (Houghton
et al., 2006).
Our data strongly suggest that NE is the major protease responsible for BP180 degradation
based on following observations: 1) both purified NE and degranulated neutrophil
supernatant produce identical degradation products of the recombinant mBP180; 2) NE
inhibitor α1-PI completely inhibits the recombinant mBP180 degradation by degranulated
neutrophil supernatant; and 3) supernatant from degranulated NE-deficient neutrophils fails
to cleave BP180. Our present findings are very likely to be relevant to human BP. Our data
show that NE directly cleaves human native BP180 trimer. It has been reported that human
BP blister fluids contain high levels of NE, and degradation of recombinant human BP180
by BP blister fluid depends on NE activity (Verraes et al., 2001). It remains to be determined
whether NE cleaves BP180 at the same or similar site as mBP180, leading to generation of
p561-like chemotactic peptides in patients with BP. Besides NE, MMP-9, cathepsin G,
collagenase, plasmin, and plasminogen activators have also been detected in BP blister fluid
and within lesional/perilesional skin sites on BP patients (Janoff, 1985; Senior and
Campbell, 1983; Weiss, 1989;Gissler et al., 1992; Grando et al., 1989a; Grando et al.,
1989b; Kramer and Reinartz, 1993; Oikarinen et al., 1983; Stahle-Backdahl et al., 1994;
Welgus et al., 1986). MMP-9 is capable of cleaving the recombinant human BP180 NC16A
domain (Stahle-Backdahl et al., 1994). Therefore, our data cannot rule out the possibility
that some of these proteases are involved, either directly or indirectly through interaction
with NE, in BP blistering.
In summary, the data presented here strongly suggest that NE is important for BP disease
development. NE directly cleaves the hemidesmosomal protein BP180 and generates
peptides with neutrophil chemotactic activity to amplify the inflammatory cascade in mice.
Our data present a new possible target for treatment in human BP.
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Human neutrophil elastase, α1-proteinase inhibitor (α1-PI), and myeloperoxidase (MPO)
were from Athens Research and Technology, Inc. (Athens, Georgia). Phorbol myristate
acetate (PMA) was obtained from Sigma Co. (St. Louis, MO). Methoxysuccinyl-Ala-Ala-
Pro-Val-p-nitroanalide (Met-OSuc-Ala-Ala-Pro-Val-pNA, or AAPV) was from Enzyme
Systems Products (Dublin, CA). Protein concentration was determined with the RC DC
protein assay purchased from Bio-Rad Laboratories (Hercules, CA). The ECL Western
blotting analysis kit was purchased from GE Healthcare (Piscataway, NJ).
4.2. Laboratory animals
Breeding pairs of C57BL/6J mice were purchased from Jackson Laboratories (Bar Harbor,
ME). NE null mutants (NE−/−) and the matched control littermates (NE+/+) were generated
as described previously (Belaaouaj et al., 1998). These animals were maintained at the
University of North Carolina at Chapel Hill Animal Resource Center. Neonatal mice (24-36
h old with body weights between 1.4 and 1.6 g) were used for in vivo experiments. All
animal care and animal experiments were approved by the UNC Animal Care Committee
and were in accordance with the National Institutes of Health guidelines.
4.3. Preparation of pathogenic anti-BP180 IgG
The preparation of recombinant murine BP180 and the immunization of rabbits were
performed as previously described (Liu et al., 1993). Briefly, a segment of the ectodomain
of the murine BP180 antigen (Li et al., 1993) was expressed as a glutathione S-transferase
(GST) fusion protein using the pGEX prokaryotic expression system (Pharmacia LKB
Biotechnology, Piscataway, NJ). The murine BP180 fusion protein, designated GST-
mBP180ABC containing NC14A and half of C13 domains (Figure 1C), was purified to
homogeneity by affinity chromatography using a glutathione-Agarose column (Liu et al.,
1992). New Zealand White rabbits were immunized with the purified mBP180 fusion
protein and the IgG fraction from the serum (designated R621) was purified as previously
described (Liu et al., 1993). The IgG fractions were concentrated, sterilized by ultrafiltration
and the protein concentrations determined by OD280 [E (1%, 1 cm) = 13.6]. The titers of
anti-murine BP180 antibodies in both the unfractionated rabbit serum and in the purified
IgG fraction were assayed by indirect immunofluorescence (IF) using mouse skin
cryosections as substrate. The antibody preparations were also tested by immunoblotting
against the GST-mBP180ABC fusion protein. The IF and immunoblotting techniques have
been reported elsewhere (Liu et al., 1993).
4.4. Neutrophil elastase digestion and analysis of mBP180 peptides
The GST portion of the GST-mBP180ABC fusion protein was removed by PreScission
protease cleavage, followed by glutathione column. Purified mBP180ABC protein (4μg)
was incubated with highly purified human NE (0.02 μg) in the in vitro degradation buffer
containing 50 mM Tris-Cl, pH 7.5, and 1 mM DTT. Reactions were carried out at 37°C for 0
– 2 hours and terminated by adding an equal volume of SDS-PAGE sample buffer and
heating at 100°C for 5 minutes. Reaction mixtures were then resolved by electrophoresis
through 21% SDS-PAGE gels. The mBP180ABC and its degraded fragments were detected
using Coomassie blue staining and immunoblotting using rabbit anti-mBP180 IgG. The NE-
generated peptides of mBP180ABC were analyzed by MS- mass spectrometry (UNC-Duke
Proteomics Center, University of North Carolina at Chapel Hill).
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4.5. Neutrophil isolation, in vitro neutrophil degranulation, and digestion of mBP180ABC
by degranulated neutrophil supernatants
Neutrophils were isolated from heparinized blood of wild-type and NE-deficient mice by
dextran sedimentation followed by separation on a density gradient as described (Metcalf,
1985). In vitro neutrophil degranulation was performed as described (Desrochers et al.,
1992). Purified neutrophils from NE+/+ and NE−/− mice were suspended in Hank's
balanced salt solution (GIBCO) at a final concentration of 107 cells/ml and triggered with 50
ng/ml phorbol myristate acetate for 15 min at 37°C. The neutrophil supernatants were
collected by centrifugation at 1,000 g for 5 min at 4°C. The supernatants (5 μl) were
incubated with purified mBP180ABC (4 μg) at 37°C for 30 min in the absence or presence
of the NE inhibitor, α1-PI. Reaction mixtures were resolved by 21% SDS-PAGE gels, and
the mBP180ABC and its degraded fragments were detected by immunoblotting using rabbit
anti-mBP180 IgG.
4.6. Neutrophil chemotaxis assays
PMN chemotaxis was quantified using a modification of the Boyden chamber technique
(Betsuyaku et al., 1999). A cell suspension containing 3.0 × 106 PMN/ml (the total cell
number loaded per well was adjusted to give equal numbers of PMNs) in HBSS with 1 mM
CaCl2, 1 mM MgCl2 containing 0.1% BSA, was placed in the top wells of a 48-well
microchemotaxis chamber (Neuro Probe Inc., Bethesda, Maryland, USA). A
polyvinylpyrolidone (PVP)-free polycarbonate filter (3-μm pore size; Poretics Products,
Livermore, California, USA) separated the cells from lower wells containing the indicated
chemoattractant. The chamber was incubated for 90 min at 37°C in a 5% CO2 humidified
atmosphere. After incubation, the filter was stained with LeukoStat (Fisher Scientific Co.,
Pittsburgh, Pennsylvania, USA), and the number of PMNs on the undersurface of the filter
was counted in five random high-power fields (×400) for each of triplicate filters.
For in vivo chemotaxis assay, neonatal C57BL/6J mice (1–2 days old) were injected
intradermally with 50 μl of PBS, NE-digested mBP180 peptides (10−5 – 10−6 M in PBS), or
IL-8 (10−7 M). Four h later, skin sections at the injection sites were obtained, and infiltrating
neutrophils were quantified by measuring MPO enzyme activity in the skin protein extracts
as described below.
4.7. Quantification of PMN accumulation in the mouse skin
Tissue myeloperoxidase (MPO) activity was used as an indicator of PMNs within skin
samples of experimental animals, as described elsewhere (Bradley et al., 1982). A standard
reference curve was first established by obtaining activity levels on aliquots of known
amounts of purified MPO. The mouse skin samples were extracted by homogenization in a
buffer containing 0.1 M Tris-Cl, pH 7.6, 0.15 M NaCl, 0.5% hexadecyltrimethylammonium
bromide. MPO activity levels in supernatant fractions were determined by the change in
optical density at 460 nm resulting from decomposition of H2O2 in the presence of o-
dianisidine. MPO content was expressed as relative MPO activity (OD460nm /mg protein).
Protein concentrations were determined by the Bio-RAD dye binding assay using BSA as a
standard.
4.8. Digestion of epidermis and native BP180 trimer by neutrophil elastase
Fresh neonatal mouse skin or human foreskin was incubated in MEM medium containing 10
mM dithiothreitol (dTT) for 60 minutes at room temperature to separate the epidermis from
the dermis. The epidermis was washed three times with PBS, and then 10 mg of epidermis
was incubated in 100 μl PBS with or without 0.5 μg NE for 30 minutes at 37°C. The
epidermis was washed four times with PBS and the epidermal proteins were extracted by
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mechanical homogenization for two minutes on ice in buffer containing 65mM Tris-HCl,
20mM EDTA, 2mM PMSF, 2% SDS, 0.5% NP-40, pH 6.8 plus proteinase inhibitors.
Protein extracts were analyzed for BP180 degradation by immunoblot.
To detect degradation of native human BP180 trimer by NE, human BP180/type XVII was
extracted from normal human keratinocytes as described previously(Schumann et al., 2000).
Normal human keratinocyte extract (50 μl) was incubated with highly purified human NE
(0.05 μg) at 37°C for 30 minutes. Reaction mixtures were then resolved by electrophoresis
through 6% and 18% SDS-PAGE gels. The human collagen XVII and its degraded
fragments were detected by immunoblotting using anti-mBP180 IgG.
4.9. Statistical analysis
The data were expressed as mean ± SEM and were analyzed using Student's t-test. A p value
less than 0.05 was considered significant.
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> Neutrophil elastase (NE) is required for experimental bullous pemphigoid.
> NE directly cleaves BP180 in mouse and human skin.
> Recombinant murine BP180 is degraded into small peptides by NE.
> One small peptide is chemotactic for neutrophils in mice both in vitro and in
vivo.
> Local injection of neutrophil elastase recruits neutrophils to the skin in mice.
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Figure 1. Neutrophil elastase cleaves BP180
mBP180ABC containing NC14A and N-terminal half of C13 domains (see panel C) (4 μg)
was incubated with neutrophil elastase (NE, 0.02 μg) at 37°C for 0–2 h. Degradation
products of mBP180ABC were then resolved by 21% SDS-PAGE, visualized by Coomassie
blue (CB) staining and immunoblotting, and analyzed by mass spectrometry. (A) CB
staining. Fragments of approximately 15 kD, 12 kD, and 8 kD were generated from the
cleavage of mBP180ABC by NE (lanes 2–6). No degradation products were seen after
incubation for 2 h without NE (lane 7). (B) Immunoblotting. Anti-mBP180ABC IgG
identified three fragments with molecular weights of approximately 15 kD, 12 kD, and 8 kD
(lanes 2–6). (C) NE cleavage sites. The location of mBP180ABC and the NE cleavage sites
within the mBP180ABC are depicted. The schematic diagram at the left is a structural
representation of mouse BP180. The horizontal black bar designates the transmembrane
domain (TM). The COOH-terminal extracellular region is made up of 13 collagen triple-
helical (open bar) and 14 noncollagenous (closed bar) domains. NC14A represents the 14th
noncollagenous domain and C13 the 13th collagenous domain. The purified recombinant
mBP180ABC protein is a 145 amino acid fragment of the mBP180 extracellular domain,
made up of an 8-kD NC14A (closed bar) and an 8-kD half of C13 (open bar). The
degradation products were excised from Coomassie-stained PVDF membranes and
subjected to sequencing analysis. NE cleaved mBP180ABC at 3 sites (amino acid positions
506, 561, and 592).
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Figure 2. Neutrophil elastase is the major neutrophil proteinase for BP180 degradation
mBP180ABC (4 μg) was incubated with buffer control (lane 1), 0.02 μg of NE (lane 2),
degranulated neutrophil supernatant (5 μl) from wild-type mice (NE+/+, lane 3), NE+/+ in the
presence of α1-PI (lane 4), or NE-deficient mice (NE−/−, lane 5) at 37°C for 30 min.
Degradation products of mBP180ABC were separated on 21% SDS-PAGE and analyzed by
immunoblotting using antibodies directed against the mBP180ABC. Degranulated
neutrophil supernatants from NE+/+ and not NE−/− mice cleaved mBP180ABC and its
proteolytic activity was completely abolished by addition of the NE inhibitor α1-PI.
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Figure 3. Neutrophil elastase-cleaved BP180 fragments are chemotactic for neutrophils in vitro
and in vivo
(A) Chemotaxis assays were performed using mouse neutrophils placed in the upper
compartment of a modified Boyden chamber. Buffer control, peptides p506, p561, and p592
(10−5 – 10−7 M), or fMLP (10−5 M) were placed in the lower compartment as the
chemoattractant. The average number of migrated neutrophils per high powered field in
triplicate wells from three separate experiments was determined. The peptide p561, but not
p506 and p592, exhibits chemotactic activity for neutrophils in a dose-dependent fashion
(bars 6–8). *p<0.05 (p561 vs. buffer control), Student t-test. (B) Neonatal C57BL/6J mice
(1–2 days old) were administrated intradermally with PBS, peptides p506, p561, and p592
(10−5 – 10−6 M in 50 μl PBS), or IL-8 (10−7 M). Four h later, skin sections at the injection
sites were obtained, and infiltrating neutrophils were quantified by measuring MPO enzyme
activity in the skin protein extracts. Significantly increased levels of infiltrating neutrophils
are present in the p561-injected mouse skin (bars 5,6) as compared to the p506- (bars 3,4)
and p592-injected (bars 7,8) mouse skin. Levels of neutrophil infiltration were expressed as
relative MPO activity (mean OD460nm reading + SEM/mg protein). n=3 for each group,
*p<0.05 (p561 vs. buffer control), Student t-test.
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Figure 4. Local injection of NE induces neutrophil infiltration in mice
Neonatal mice were injected intradermally with 100 μl of NE (100 μg/ml in PBS) in the
absence and presence of the NE inhibitor α1-proteinase inhibitor (α1-PI) and the skin
sections were examined at different time points. (A) H/E staining. The skin sections were
examined by routine H/E staining. The skin sections treated with NE showed neutrophil
infiltration at 8 and 24 h and dermal-epidermal separation at 24 h post injection. X100
magnification. E, epidermis. D, dermis. V, vesicle. Arrow, basal keratinocyte. (B) MPO
assay. Neutrophil infiltration in the NE injection sites were quantified by MPO assay at
different time points post NE injection and expressed as relative MPO activity (mean
OD460nm reading + SEM/mg protein). Significantly increased levels of infiltrating
neutrophils in NE-injected mouse skin were seen at 4, 8, 12 and 24 h as compared to those
injected with NE plus α1-PI. *p<0.05. n=3. (C) Mouse epidermis was incubated at 37°C in
PBS alone for 0 (lane 1) or 30 minutes (lane 2), in the presence of NE (lane 3) or NE plus
α1-PI (lane 4), for 30 minutes. Protein extracts were separated by SDS-PAGE and analyzed
by immunoblotting with a rabbit anti-mouse BP180 antibody. Significant degradation of
BP180 was observed only in the reaction containing NE. Addition of α1-PI completely
abolished degradation of BP180.
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Figure 5. NE cleaves native human BP180
(A). Human foreskin epidermis was incubated at 37°C in PBS without (lane 1) or with NE
(lane 2) for 30 minutes. Protein extracts were separated by SDS-PAGE and analyzed by
immunoblotting with a rabbit anti-BP180NC16A antibody. (B) Protein extracts of cultured
human primary keratinocytes were incubated in the presence (lanes 3, 4) or absence (lanes 1,
2) of NE at 37°C for 30 min. The digestion mixtures were separated in 6% and 18% SDS
under native (lanes 1, 2) or denaturing/reducing conditions (lanes 3, 4), and then probed with
rabbit anti-BP180NC16A antibody. Under native conditions, the full-length BP180 trimer
(top panel, lane 1) was degraded into a lower molecular weight trimer band (top panel, lane
3). A band corresponding to a small BP180 fragment was identified on the 18% SDS-PAGE
gel.
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